Gray Platelet Syndrome Overview
Learn About Gray Platelet Syndrome
Gray platelet syndrome is a bleeding disorder associated with abnormal platelets, which are small blood cells involved in blood clotting. People with this condition tend to bruise easily and have an increased risk of nosebleeds (epistaxis). They may also experience abnormally heavy or extended bleeding following surgery, dental work, or minor trauma. Women with gray platelet syndrome often have irregular, heavy periods (menometrorrhagia). These bleeding problems are usually mild to moderate, but they have been life-threatening in a few affected individuals.
Gray platelet syndrome can be caused by mutations in the NBEAL2 gene. Little is known about the protein produced from this gene. It appears to play a role in the formation of alpha-granules, which are sacs inside platelets that contain growth factors and other proteins that are important for blood clotting and wound healing. In response to an injury that causes bleeding, the proteins stored in alpha-granules help platelets stick to one another to form a plug that seals off damaged blood vessels and prevents further blood loss.
Gray platelet syndrome appears to be a rare disorder. About 60 cases have been reported worldwide.
When gray platelet syndrome is caused by NBEAL2 gene mutations, it has an autosomal recessive pattern of inheritance, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene in each cell.
Barts Health NHS Trust
Janine Collins practices in London, United Kingdom. Ms. Collins is rated as an Elite expert by MediFind in the treatment of Gray Platelet Syndrome. Her top areas of expertise are Gray Platelet Syndrome, Acquired Amegakaryocytic Thrombocytopenia, Thrombocytopenia, and Dehydration.
Remi Favier practices in Paris, France. Ms. Favier is rated as an Elite expert by MediFind in the treatment of Gray Platelet Syndrome. Her top areas of expertise are Gray Platelet Syndrome, Thrombocytopenia, MYH9 Related Thrombocytopenia, and RUNX1 Familial Platelet Disorder.
Ana Glembotsky practices in Argentina. Ms. Glembotsky is rated as an Elite expert by MediFind in the treatment of Gray Platelet Syndrome. Her top areas of expertise are Gray Platelet Syndrome, Thrombocytopenia, RUNX1 Familial Platelet Disorder, and Adult Immune Thrombocytopenia.
Published Date: September 01, 2014
Published By: National Institutes of Health